Correlation Between Karyopharm Therapeutics and Replimune
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Replimune Group, you can compare the effects of market volatilities on Karyopharm Therapeutics and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Replimune.
Diversification Opportunities for Karyopharm Therapeutics and Replimune
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Karyopharm and Replimune is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Replimune go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Replimune
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to generate 2.1 times more return on investment than Replimune. However, Karyopharm Therapeutics is 2.1 times more volatile than Replimune Group. It trades about 0.04 of its potential returns per unit of risk. Replimune Group is currently generating about -0.18 per unit of risk. If you would invest 67.00 in Karyopharm Therapeutics on October 15, 2024 and sell it today you would earn a total of 1.18 from holding Karyopharm Therapeutics or generate 1.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Karyopharm Therapeutics vs. Replimune Group
Performance |
| Timeline |
| Karyopharm Therapeutics |
| Replimune Group |
Karyopharm Therapeutics and Replimune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karyopharm Therapeutics and Replimune
The main advantage of trading using opposite Karyopharm Therapeutics and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |